An observational study in Total Knee Arthroplasty, sponsored by Smith & Nephew, Inc.. Completed at 12 sites in 3 countries. Per ClinicalTrials.gov, last updated 2019-03-28.
Sponsored by Smith & Nephew, Inc. · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Arthritis, Rheumatoid by Smith & Nephew, Inc. — none open to participants now, 1 under way, none of them phase 3. Arthritis, Rheumatoid · Smith & Nephew, Inc..
Among the 13 studies in Arthritis, Rheumatoid by Smith & Nephew, Inc., this one is the only one that started in 2016, is one of 8 observational ones, and was the 9th registered.
3,338 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.
Browse Arthritis, Rheumatoid studies →None of the 13 studies in Arthritis, Rheumatoid by Smith & Nephew, Inc. is open now. The open studies under Arthritis, Rheumatoid, anywhere →
Of the 294 Arthritis, Rheumatoid studies recruiting now, 151 (51%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 1 started in 2016.
This study's enrollment of 1,694 is above the median of 176 across 1,017 observational studies indexed under Arthritis, Rheumatoid.
Median enrollment 97 across the 5 interventional studies, 104 across the 8 observational. Of the 11 that completed or were terminated, 3 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
Smith & Nephew, Inc. is the lead sponsor of 134 studies on the registry; 11 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 10 (91%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Arthritis, Rheumatoid by Smith & Nephew, Inc., from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The objective of this study is to estimate the safety and performance of Journey II BCS TKS.
The objective of this study is to estimate the safety and performance of Journey II BCS TKS. Specifically, the study will establish revision rate, treatment- and device-related complications, and clinical outcomes in a large sample of subjects who received the study device. Subjects are screened consecutively, beginning at the earliest date of implantation at each investigative site. Further, reasons for revision will be collected and analyzed. An analysis will be performed to identify characteristics (patient, surgeon and surgical) associated with an increased risk for revision. Finally, clinical, functional and quality of life outcomes will be analyzed to the extent data is available, given the retrospective study design.
Sites will identify potential subjects by retrospectively reviewing their source documents in order to identify all patients who received TKA with the Journey II BCS TKS.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Subjects having TKA with Journey II BCS Total Knee System
Device: Journey II BCS Total Knee System
Revision Rate of Total Knee System
Number of revisions
Time frame: implantation through study completion, approximately 3 years
Adverse Events
Number of adverse events reported per ISO 14155 guidelines
Time frame: implantation through study completion, approximately 3 years
Health care utilization: Hospitalization
Length of hospital stay for primary (index) surgery
Time frame: implantation through study completion, approximately 3 years
Health care utilization: Hospitalization
Hospitalizations (admission for inpatient care) occurring after the hospitalization for the index surgery (number and length of stay)
Time frame: implantation through study completion, approximately 3 years
Health care utilization: Rehabilitation
number of sessions and duration of rehabilitation in weeks
Time frame: implantation through study completion, approximately 3 years
Health care utilization: Outpatient visits
Number and type of outpatient visits
Time frame: implantation through study completion, approximately 3 years
Health Care Utilization: Re-operations
number of re-operations and revisions
Time frame: implantation through study completion, approximately 3 years
Patient reported outcomes
EQ-5D-3L
Time frame: implantation through study completion, approximately 3 years
Clinical outcomes
Knee Society Score
Time frame: implantation through study completion, approximately 3 years
Return to Work
Changes in employment status will be recorded with the date on which the change occurred and the change status.
Time frame: implantation through study completion, approximately 3 years
Technical Difficulties Encountered During Device Implantation
Number of technical difficulties encountered with the device
Time frame: implantation through study completion, approximately 3 years
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2016 to primary completion in Jan 2018, 13 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.